Investigation and analysis of appetite status in patients with lymphoma during chemotherapy
10.3760/cma.j.cn115356-20220303-00062
- VernacularTitle:淋巴瘤患者化疗期食欲现状调查与分析
- Author:
Rongrong CHEN
1
;
Meihua CHEN
;
Huazhen HUANG
;
Yufang WANG
Author Information
1. 福建医科大学附属协和医院血液科 福建省血液病研究所 福建省血液病学重点实验室，福州 350001
- Keywords:
Lymphoma;
Antineoplastic combined chemotherapy protocols;
Appetite;
Influencing factors;
Cross-sectional studies
- From:
Journal of Leukemia & Lymphoma
2023;32(6):348-351
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the appetite of patients with lymphoma during chemotherapy and its influencing factors.Methods:A total of 103 patients with lymphoma who underwent chemotherapy were sequentially selected in Fujian Medical University Union Hospital from December 2020 to August 2021. The questionnaire survey was carried out by using general information and Karnofsky score was performed. Appetite score was calculated according to Chinese version of the appetite symptom questionnaire for cancer patients. Multiple linear regression analysis was used to analyze the influencing factors of appetite status of lymphoma patients during chemotherapy, and Pearson correlation analysis was used to explore the relationship between Karnofsky score and appetite score of patients.Results:For patients with lymphoma during chemotherapy, Karnofsky score was (75±18) scores and the appetite score was (25.0±5.0) scores. Univariate analysis showed that age, body mass index (BMI), nausea and vomiting, oral mucosa rupture, gum infection, fever, throat infection were influencing factors of appetite score of patients (all P < 0.05). Multivariate analysis showed that patients ' age ( B = -1.118, β = -0.187, P = 0.016), BMI ( B = -2.047, β = -0.271, P = 0.001), nausea and vomiting ( B = -4.352, β = -0.411, P < 0.001) were the independent influencing factors of appetite score. Correlation analysis showed that the Karnofsky score was positively correlated with appetite score ( r = 0.361, P < 0.05). Conclusions:Special attention should be paid to the appetite of elder lymphoma patients with lower BMI during chemotherapy, and nausea and vomiting should be paid more attention; targeted measures of increasing the patients' appetite could improve their nutritional level and prognosis.
